Germany
· Delayed Price · Currency is EUR Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of EUR 114.13 billion. The enterprise value is 124.84 billion.
| Market Cap | 114.13B |
| Enterprise Value | 124.84B |
Important Dates
The next estimated earnings date is Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | May 12, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 18.12.
| PE Ratio | 18.12 |
| Forward PE | n/a |
| PS Ratio | 2.53 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 5.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 19.82 |
| EV / Sales | 2.76 |
| EV / EBITDA | 10.08 |
| EV / EBIT | 12.97 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 1.46 |
| Debt / FCF | n/a |
| Interest Coverage | 15.62 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 6.28% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 544,970 |
| Profits Per Employee | 76,003 |
| Employee Count | 82,878 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.00% in the last 52 weeks. The beta is 0.48, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +6.00% |
| 50-Day Moving Average | 101.71 |
| 200-Day Moving Average | 98.55 |
| Relative Strength Index (RSI) | 42.73 |
| Average Volume (20 Days) | 15,824 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of EUR 45.17 billion and earned 6.30 billion in profits. Earnings per share was 5.04.
| Revenue | 45.17B |
| Gross Profit | 32.05B |
| Operating Income | 9.48B |
| Pretax Income | 7.87B |
| Net Income | 6.30B |
| EBITDA | 12.23B |
| EBIT | 9.48B |
| Earnings Per Share (EPS) | 5.04 |
Balance Sheet
The company has 7.56 billion in cash and 17.91 billion in debt, giving a net cash position of -10.36 billion.
| Cash & Cash Equivalents | 7.56B |
| Total Debt | 17.91B |
| Net Cash | -10.36B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 77.86B |
| Book Value Per Share | 61.83 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.96%, with operating and profit margins of 20.99% and 13.95%.
| Gross Margin | 70.96% |
| Operating Margin | 20.99% |
| Pretax Margin | 17.41% |
| Profit Margin | 13.95% |
| EBITDA Margin | 27.09% |
| EBIT Margin | 20.99% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.92, which amounts to a dividend yield of 4.26%.
| Dividend Per Share | 3.92 |
| Dividend Yield | 4.26% |
| Dividend Growth (YoY) | 4.26% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | 4.29% |
| Earnings Yield | 5.52% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |